Abstract:Background: Colon cancer is one of the most prevalent digestive cancers worldwide. Results of epidemiological, experimental, and clinical studies suggest that aspirin inhibits the development of colon cancer. This study aimed to systematically elucidate the molecular mechanisms by which aspirin prevents colon carcinogenesis. Methods: We determined the global protein expression profiles of colorectal cancer and aspirin-treated cells using quantitative proteomic analysis. We analyzed the proteomic results using bioinformatics (including differential proteins, protein annotation, Kyoto Encyclopedia of Genes and Genomes [KEGG] pathways, and protein-protein interaction [PPI] network). The viability of the colon cancer cell line and HT29 cells treated with aspirin was determined using the cell counting kit-8 assay. The differentially expressed proteins, such as p53 and cyclin-dependent kinase 1 (CDK1), were quantified using real-time polymerase chain reaction (PCR) and Western blotting. We measured cell cycle distribution and apoptosis in HT29 cells exposed to aspirin using fluorescence-activated cell sorting (FACS). Results: We found that 552 proteins were significantly dysregulated, of which 208 and 334 were upregulated and downregulated, respectively, in colon cancer cells exposed to 10 mmol/L of aspirin (95% confidence interval [CI]: -1.269 to -0.106, P < 0.05). Further gene enrichment analysis revealed that cell cycle-related proteins, such as p53 and CDK1, were significantly differentially expressed. Proteomic analysis showed that after 24 h of aspirin exposure, the level of p53 increased by 2.52-fold and CDK1 was downregulated to half that of the controls in HT29 cells (95% CI: -0.619 to -0.364, P < 0.05). Real-time PCR and Western blotting results showed that p53 was upregulated (95%CI: -3.088 to -1.912, P < 0.001) and CDK1 was significantly downregulated after aspirin exposure in colon cancer cells (95% CI: 0.576 to 1.045, P < 0.05). We observed that aspirin promoted G1/S cell cycle arrest in HT29 cells. We confirmed that aspirin induces apoptosis in human HT29 colon cancer cells in a concentration-dependent manner. Conclusions: These results indicate that aspirin induces G1 arrest and apoptosis in colorectal cancer cells via the p53-CDK1 pathway. Aspirin may be a promising drug candidate for colon cancer prevention.

Role Of P38 Mapk In Enhanced Human Cancer Cells Killing By The Combination Of Aspirin And Abt-737

Aspirin Disrupts the Mtor-Raptor Complex and Potentiates the Anti-Cancer Activities of Sorafenib Via Mtorc1 Inhibition.

Use of aspirin in the prevention of colorectal cancer through TIGIT-CD155 pathway.

Aspirin Exerts High Anti-Cancer Activity in PIK3CA-mutant Colon Cancer Cells

Aspirin Cooperates with P300 to Activate the Acetylation of H3K9 and Promote FasL-mediated Apoptosis of Cancer Stem-Like Cells in Colorectal Cancer

Aspirin Prevent Colorectal Cancer Via <i>enterococcus Cecorum</i> -TIGIT <sup>+</sup>treg Cell Axis

Aspirin Induces Immunogenic Cell Death and Enhances Cancer Immunotherapy in Colorectal Cancer

Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter

Experimental Study on Inhibitive Effecs of Aspirin on the Proliferation of Human Lung Cancer Cells

Triptolide-Assisted Phosphorylation of p53 Suppresses Inflammation-Induced NF-κB Survival Pathways in Cancer Cells.

Repositioning Aspirin to Treat Lung and Breast Cancers and Overcome Acquired Resistance to Targeted Therapy.

Aspirin Regulates Gemcitabine Resistance in Pancreatic Cancer via Inhibiting the PI3K/Akt/mTOR Signaling Pathway and Reversing Epithelial-mesenchymal Transition

Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (programmed Cell Death 1 Ligand 1) Expression Status.

Aspirin Potentiates Celecoxib-Induced Growth Inhibition and Apoptosis in Human Non-Small Cell Lung Cancer by Targeting GRP78 Activity.

Enhanced Anti-tumor Efficacy of Aspirin Combined with Triptolide in Cervical Cancer Cells

Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner

Effects of aspirin on colon cancer using quantitative proteomic analysis

The Tgf-Beta Induced Gene, Pmepa1, Attenuates Antitumor Efficacy Of Aspirin In Triple-Negative Breast Cancer By Regulating Tgf-Beta 1

Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA -mutatnt colorectal cancer

[Aspirin inhibits the proliferation of breast cancer cells via inducing apoptosis and autophagy].

Synergistic Effect of Nutlin-3 Combined with Aspirin in Hepatocellular Carcinoma HepG2 Cells Through Activation of Bcl-2/Bax Signaling Pathway